Xanthone

Overview

Xanthone is a monoamine oxidase A ( MAO-A ) inhibitor with an IC 50 of 0.84 µM. Xanthon inhibits Norepinephrine ( HY-13715 ) and high-K + -induced vasoconstriction with IC 50 values of 60.26 μM and 82.9 μM, respectively. Xanthon increases intracellular cyclic adenosine 3′,5′-monophosphate (cAMP) content and blocks Ca 2+ channels. Xanthone is the scaffold of several pharmacologically active compounds.

Application

Products | Products > Disease Areas > Neurodegenerative Disease | Products > Disease Areas > Cardiovascular Disease | Products > Disease Areas > Depression | Products > Disease Areas > Parkinson's Disease | Products > Disease Areas > Hypertension | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Signaling Pathways > Others | Products > Signaling Pathways > Neuronal Signaling | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Research Areas > Neurological Disease | Products > Research Areas > Cardiovascular Disease | Products > Signaling Pathways > Environmental Pollutants | Products > Signaling Pathways > Monoamine Oxidase | Products > Signaling Pathways > Calcium Channel

Product Information

• Catalog No.: HY-N0126
• CAS No.: 90-47-1
• Molecular Formula: C13H8O2
• Molecular Weight: 196.21
• Purity: 99.97%
• Storage: Store at room temperature 3 years. In solvent -80°C, 2 years , -20°C, 1 year
• Solubility: ≥ 1 mg/mL (5.10 mM); Clear solution
• Availability: In-stock

Source

Original product source